Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus

Most HIV transmission in women occurs through the cervicovaginal mucosa, which is coated by a bacterial biofilm including Lactobacillus. This commensal bacterium plays a role in maintaining healthy mucosa and can be genetically engineered to produce anti-viral peptides. Here, we report a 63% reducti...

Full description

Bibliographic Details
Main Authors: Lagenaur, Laurel A, Sanders-Beer, Brigitte E, Brichacek, Beda, Pal, Ranajit, Liu, Xiaowen, Liu, Yang, Yu, Rosa, Venzon, David, Lee, Peter P, Hamer, Dean H
Format: Online
Language:English
Published: 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433722/
id pubmed-3433722
recordtype oai_dc
spelling pubmed-34337222012-09-05 Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus Lagenaur, Laurel A Sanders-Beer, Brigitte E Brichacek, Beda Pal, Ranajit Liu, Xiaowen Liu, Yang Yu, Rosa Venzon, David Lee, Peter P Hamer, Dean H Article Most HIV transmission in women occurs through the cervicovaginal mucosa, which is coated by a bacterial biofilm including Lactobacillus. This commensal bacterium plays a role in maintaining healthy mucosa and can be genetically engineered to produce anti-viral peptides. Here, we report a 63% reduction in transmission of a chimeric simian/human immunodeficiency virus (SHIVSF162P3) after repeated vaginal challenges of macaques treated with Lactobacillus jensenii expressing the HIV-1 entry inhibitor cyanovirin-N. Furthermore, peak viral loads in colonized macaques with breakthrough infection were reduced 6-fold. Colonization and prolonged anti-viral protein secretion by the genetically engineered lactobacilli did not cause any increase in proinflammatory markers. These findings lay the foundation for an accessible and durable approach to reduce heterosexual transmission of HIV in women that is coitally independent, inexpensive, and enhances the natural protective effects of the vaginal microflora. 2011-07-06 2011-11 /pmc/articles/PMC3433722/ /pubmed/21734653 http://dx.doi.org/10.1038/mi.2011.30 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Lagenaur, Laurel A
Sanders-Beer, Brigitte E
Brichacek, Beda
Pal, Ranajit
Liu, Xiaowen
Liu, Yang
Yu, Rosa
Venzon, David
Lee, Peter P
Hamer, Dean H
spellingShingle Lagenaur, Laurel A
Sanders-Beer, Brigitte E
Brichacek, Beda
Pal, Ranajit
Liu, Xiaowen
Liu, Yang
Yu, Rosa
Venzon, David
Lee, Peter P
Hamer, Dean H
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
author_facet Lagenaur, Laurel A
Sanders-Beer, Brigitte E
Brichacek, Beda
Pal, Ranajit
Liu, Xiaowen
Liu, Yang
Yu, Rosa
Venzon, David
Lee, Peter P
Hamer, Dean H
author_sort Lagenaur, Laurel A
title Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
title_short Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
title_full Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
title_fullStr Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
title_full_unstemmed Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
title_sort prevention of vaginal shiv transmission in macaques by a live recombinant lactobacillus
description Most HIV transmission in women occurs through the cervicovaginal mucosa, which is coated by a bacterial biofilm including Lactobacillus. This commensal bacterium plays a role in maintaining healthy mucosa and can be genetically engineered to produce anti-viral peptides. Here, we report a 63% reduction in transmission of a chimeric simian/human immunodeficiency virus (SHIVSF162P3) after repeated vaginal challenges of macaques treated with Lactobacillus jensenii expressing the HIV-1 entry inhibitor cyanovirin-N. Furthermore, peak viral loads in colonized macaques with breakthrough infection were reduced 6-fold. Colonization and prolonged anti-viral protein secretion by the genetically engineered lactobacilli did not cause any increase in proinflammatory markers. These findings lay the foundation for an accessible and durable approach to reduce heterosexual transmission of HIV in women that is coitally independent, inexpensive, and enhances the natural protective effects of the vaginal microflora.
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433722/
_version_ 1611554176991494144